DE685510C - Process for the production of durable aqueous chlorophyll solutions for medical purposes - Google Patents
Process for the production of durable aqueous chlorophyll solutions for medical purposesInfo
- Publication number
- DE685510C DE685510C DEL91093D DEL0091093D DE685510C DE 685510 C DE685510 C DE 685510C DE L91093 D DEL91093 D DE L91093D DE L0091093 D DEL0091093 D DE L0091093D DE 685510 C DE685510 C DE 685510C
- Authority
- DE
- Germany
- Prior art keywords
- chlorophyll
- solutions
- production
- medical purposes
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R25/00—Arrangements for measuring phase angle between a voltage and a current or between voltages or currents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Otolaryngology (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Verfahren zur Herstellung haltbarer wäßriger Chlorophyllösungen für medizinische Zwecke Die Erfindung betrifft ein Verfahren zur Herstellung haltbarer wäßriger Chlorophyll-* lösungen für medizinische Zwecke, insbesonder für die therapeutische Behandlung einer Infektion des Blutstromes, infizierter Teile und offener Schnitte und Wunden.Process for the preparation of durable aqueous chlorophyll solutions for medical purposes The invention relates to a method for producing more durable Aqueous chlorophyll * solutions for medical purposes, in particular for therapeutic purposes Treatment of an infection of the bloodstream, infected parts, and open cuts and wounds.
Die Löslichkeit gewisser Formen von Chlorophyll in Wasser und in Ölen, wie z. B. Olivenöl, ist bereits bekannt. The solubility of certain forms of chlorophyll in water and in Oils, such as B. olive oil is already known.
Wäßrige Lösungen werden beim Lagern trübe, verwendet man jedoch eine isotonische Lösung, vorzugsweise physiologische Kochsalzlösung als Lösungsmittel, so erhält man haltbare Lösungen, die auch nach längerer Lagerung keine Ausfällung oder Trübung zeigen. Die Lösung kann unmittelbar an infizierten Teilen oder intravenös angewandt werden, sie ist für den Körper - unschädlich, sdiwächt die Batterien und verhindert ihr Wachstum und die Vermehrung. Die Lösmlg wirkt nicht antiseptisch, sondern dient als Nahrung für die Bakterien, die dadurch abgehalten werden, das Gewebe und Blut der Wirtsperson anzugreifen. Aqueous solutions become cloudy on storage, but one is used isotonic solution, preferably physiological saline solution as solvent, this gives long-lasting solutions that do not precipitate even after prolonged storage or show turbidity. The solution can be applied directly to infected parts or intravenously be used, it is harmless to the body, it weakens the batteries and prevents their growth and reproduction. The solution does not have an antiseptic effect, but serves as nourishment for the bacteria that are kept away by the Attack the host's tissues and blood.
Es wurde festgestellt, daß Bakterien bei ausschließlicher Ernährung mit Chlorophyll ihre Form ändern, sich verfärben, geschwächt werden und sich in geringerem Maße fortpflanzen, so daß der Körper Gelegenheit erhält, Granulationsgewebe zu bilden und die Bakterien auszustoßen. Ferner wird durch die Behandlung mit Chlorophyllösungen die Bildung giftiger Stoffwechselprodukte der Bakterien gehemmt. Als besonders geeignet erwies sich eine Lösung von 0,5 g im wesentlichen reinen, fein gepulverten Chlorophylls in 11 einer physiologischen Kochsalzlösung. It was found that bacteria when exclusively fed with chlorophyll change shape, become discolored, weakened and become in Propagate less so that the body has the opportunity to produce granulation tissue to form and expel the bacteria. Furthermore, by treatment with chlorophyll solutions the formation of toxic metabolic products of the bacteria is inhibited. As particularly suitable a solution of 0.5 g of essentially pure, finely powdered chlorophyll was found in 11 a physiological saline solution.
Die Verfahrensprodukte eignen sich zur Behandlung von Infektionen, von durch Staphylokolcken bedingter Osteomyelitis, von Empyema pneumokokkischen Ursprungs, des perinephritischen Abszesses, von Infektionen mit den Kolonbazillen; Bauchfellentzündung streptokokkischen Ursprungs, Sinusinfektion und streptokolddsdier Bakteriämie. The process products are suitable for the treatment of infections, of osteomyelitis caused by staphylococci, of Empyema pneumococcal Origin, perinephritic abscess, from infections with colonic bacilli; Peritonitis of streptococcal origin, sinus infection and streptokolddsdier Bacteremia.
Bei zugänglichen Eiterherden kann die Lösung auch direkt, z. B. in Form von nassen Verbänden, Umschlägen oder Tampons, angewendet werden. In the case of accessible foci of pus, the solution can also be used directly, e.g. Am In the form of wet bandages, compresses or tampons.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US685510XA | 1935-09-09 | 1935-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE685510C true DE685510C (en) | 1939-12-19 |
Family
ID=22083278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEL91093D Expired DE685510C (en) | 1935-09-09 | 1936-09-08 | Process for the production of durable aqueous chlorophyll solutions for medical purposes |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE685510C (en) |
| FR (1) | FR829224A (en) |
| GB (2) | GB486756A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402941A (en) | 1981-09-15 | 1983-09-06 | Marc Vaillancourt | Veterinary composition for preventing feline urological syndrome and litter product containing the composition |
-
1936
- 1936-09-04 GB GB24231/36A patent/GB486756A/en not_active Expired
- 1936-09-04 GB GB10811/38A patent/GB486847A/en not_active Expired
- 1936-09-08 DE DEL91093D patent/DE685510C/en not_active Expired
- 1936-09-08 FR FR829224D patent/FR829224A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR829224A (en) | 1938-06-16 |
| GB486847A (en) | 1938-06-07 |
| GB486756A (en) | 1938-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3761590A (en) | Silver sulfadiazine used in the treatment of burns | |
| US2726982A (en) | Hydrous gels | |
| CA1050548A (en) | Zinc sulfadiazine as a medicament | |
| DE69726457T2 (en) | PHARMACEUTICAL COMPOSITIONS WITH ANTIMICROBIAL EFFECT | |
| US2115492A (en) | Pharmaceutical products adapted for injection into the human body | |
| US4232003A (en) | Synthetic physiological mucus | |
| US5575995A (en) | Ferric subsulfate gel and methods of using same | |
| US3965908A (en) | Synthetic physiological mucus | |
| DE2202964A1 (en) | Stable, mild, non-toxic, camphor-containing preparations for topical treatment with anti-inflammatory, antipruretic and antibacterial effects | |
| DE685510C (en) | Process for the production of durable aqueous chlorophyll solutions for medical purposes | |
| EP0366888B1 (en) | Pharmaceutical preparation for treating inflammations of the nasal mucous membranes | |
| DE1442134C3 (en) | In vivo anticoagulant and defibrinating enzyme | |
| GB2274988A (en) | Iodine containing wound-healing preparations | |
| EP0014238A2 (en) | Mucilagenous synthetic lubricant and antifriction agent, especially for the vaginal region, and its use in diagnostic, surgical and treating medicine | |
| RU2033164C1 (en) | Antimicrobial medical preparation | |
| US2209454A (en) | Germicide | |
| DE3441835C2 (en) | ||
| DE2746761A1 (en) | USE OF 2-PYRROLIDONE DERIVATIVES FOR THE TREATMENT OF VASCULAR DISEASES IN HUMANS | |
| DE876446C (en) | Hemostatic sponge | |
| DE2246969C2 (en) | Urokinase heparinate and medicinal products containing it | |
| EP0494910B1 (en) | Eye-drops | |
| DE1667890B2 (en) | DERMATOLOGICAL AND COSMETIC EXTERNAL PRODUCTS FOR THE TREATMENT OF SKIN COLLAGENOSE | |
| DE3129685C2 (en) | Antiseptic solution | |
| DE627813C (en) | Process for the production of a disinfecting agent for protecting the skin against infections and for healing skin diseases | |
| DE868492C (en) | Method of making a medicinal product |